These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7554561)

  • 1. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity.
    Caligaris-Cappio F; Bertero MT; Converso M; Stacchini A; Vinante F; Romagnani S; Pizzolo G
    Clin Exp Rheumatol; 1995; 13(3):339-43. PubMed ID: 7554561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value.
    Ciferská H; Horák P; Hermanová Z; Ordeltová M; Zadrazil J; Tichý T; Scudla V
    Clin Rheumatol; 2007 May; 26(5):723-8. PubMed ID: 17103120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
    De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
    Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
    Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
    Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
    Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble CD30 levels in Behçet's disease.
    Düzgün N; Ayaslioglu E; Tutkak H
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S17-20. PubMed ID: 15515777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
    Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
    Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
    Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
    Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
    Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
    Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
    FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
    Lin J; Yue LH; Chen WQ
    Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma.
    Purello-D'Ambrosio F; Gangemi S; Ruello G; Marotta G; Merendino RA
    J Investig Allergol Clin Immunol; 2000; 10(5):283-5. PubMed ID: 11108439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus.
    Wu JF; Yang YH; Wang LC; Lee JH; Shen EY; Chiang BL
    J Autoimmun; 2006 Sep; 27(2):119-24. PubMed ID: 16919912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphoma.
    Nadali G; Vinante F; Stein H; Todeschini G; Tecchio C; Morosato L; Chilosi M; Menestrina F; Kinney MC; Greer JP
    J Clin Oncol; 1995 Jun; 13(6):1355-60. PubMed ID: 7751879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble CD30 level correlates negatively with age in children.
    Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
    J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.